Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase
- PMID: 16311512
- DOI: 10.1038/sj.cdd.4401801
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase
Abstract
The antioncogenic Chk2 kinase plays a crucial role in DNA damage-induced cell-cycle checkpoint regulation. Here we show that Chk2 associates with the oncogenic protein Wip1 (wild-type p53-inducible phosphatase 1) (PPM1D), a p53-inducible protein phosphatase. Phosphorylation of Chk2 at threonine68 (Thr68), a critical event for Chk2 activation, which is normally induced by DNA damage or overexpression of Chk2, is inhibited by expression of wild-type (WT), but not a phosphatase-deficient mutant (D314A) of Wip1 in cultured cells. Furthermore, an in vitro phosphatase assay revealed that Wip1 (WT), but not Wip1 (D314A), dephosphorylates Thr68 on phosphorylated Chk2 in vitro, resulting in the inhibition of Chk2 kinase activity toward glutathione S-transferase-Cdc25C. Moreover, inhibition of Wip1 expression by RNA interference results in abnormally sustained Thr68 phosphorylation of Chk2 and increased susceptibility of cells in response to DNA damage, indicating that Wip1 acts as a negative regulator of Chk2 in response to DNA damage.
Similar articles
-
Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.J Biol Chem. 2008 Jul 4;283(27):18969-79. doi: 10.1074/jbc.M800560200. Epub 2008 May 15. J Biol Chem. 2008. PMID: 18482988
-
The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase.Oncogene. 2007 Mar 1;26(10):1449-58. doi: 10.1038/sj.onc.1209927. Epub 2006 Aug 28. Oncogene. 2007. PMID: 16936775
-
Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1.J Biol Chem. 2006 Aug 25;281(34):24847-62. doi: 10.1074/jbc.M600403200. Epub 2006 Jun 23. J Biol Chem. 2006. PMID: 16798742
-
WIP1 phosphatase at the crossroads of cancer and aging.Trends Biochem Sci. 2010 Feb;35(2):109-14. doi: 10.1016/j.tibs.2009.09.005. Epub 2009 Oct 29. Trends Biochem Sci. 2010. PMID: 19879149 Review.
-
The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways.Cancer Metastasis Rev. 2008 Jun;27(2):123-35. doi: 10.1007/s10555-008-9127-x. Cancer Metastasis Rev. 2008. PMID: 18265945 Free PMC article. Review.
Cited by
-
PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.Oncogene. 2015 Nov 26;34(48):5900-11. doi: 10.1038/onc.2015.31. Epub 2015 Mar 30. Oncogene. 2015. PMID: 25823026 Free PMC article.
-
Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx.Cell Signal. 2013 Apr;25(4):796-804. doi: 10.1016/j.cellsig.2012.12.014. Epub 2012 Dec 28. Cell Signal. 2013. PMID: 23277204 Free PMC article.
-
p53 Regulates LIF expression in human medulloblastoma cells.J Neurooncol. 2010 May;97(3):373-82. doi: 10.1007/s11060-009-0043-x. Epub 2009 Nov 12. J Neurooncol. 2010. PMID: 19907922
-
LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1).PLoS One. 2011 Jan 24;6(1):e16427. doi: 10.1371/journal.pone.0016427. PLoS One. 2011. PMID: 21283629 Free PMC article.
-
Overexpression of wip1 is associated with biologic behavior in human clear cell renal cell carcinoma.PLoS One. 2014 Oct 15;9(10):e110218. doi: 10.1371/journal.pone.0110218. eCollection 2014. PLoS One. 2014. PMID: 25334029 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous